| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.15 | 0.007 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.008 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.008 |